Per AI Express, 100 grams of biology (SH 688276, **price: 5206 yuan) released the 2023 annual performance express report on the evening of February 23, with an operating income of about 182.5 billion yuan, an increase of 70 percent year-on-year3%；The net profit attributable to shareholders of the listed company is about 50.1 billion yuan, an increase of 175 percent year-on-year98%；Basic earnings per share was 121 yuan, an increase of 175% year-on-year.
From January to December 2022, the composition of Baike Bio's operating income is: biomedicine accounts for 1000%。
The chairman of Baike Biotechnology is Ma Ji, male, 58 years old, with a master's degree; The general manager is Kong Wei, male, 58 years old, with a doctorate degree.
As of press time, the market value of Baike Biotechnology is 21.5 billion yuan.
1.In the past 30 days, the northbound capital holdings of Baike Biotech have decreased by 247180,000 shares, a decrease of 1 percent of the outstanding shares02%；
2.In the past 30 days, a total of 2 batches of institutions have investigated Baike Biotech, and the total number of institutions investigated is 4.
Every headline (nbdtoutiao) - how explosive is SORA, four ** large models and 5 major scene evaluations! From ChatGPT to SORA, why OpenAI has been able to continuously create a "king-level artifact".
Reporter Jia Yunke).
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Do so at your own risk.
National Business Daily.